 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2024, vol. 30, issue3
Subject Area: Medicine
-
DOI: 10.5272/jimab.2024303.5754
Published online: 27 September 2024
Original article
J of IMAB. 2024 Jul-Sep;30(3):5754-5757
MULTIVISCERAL RESECTIONS IN CASES OF LOCALLY ADVANCED GASTRIC CANCER. PERIOPERATIVE RESULTS IN A HIGH-VOLUME CENTER
Vesselin Marinov1, 2
,
1)Department of General and Operative Surgery, Medical University - Varna, Bulgaria.
2)Clinic for Hepato-Billiary, Pancreatic and General Surgery, Acibadem City Clinic UMHAT "Tokuda" Hospital, Sofia, Bulgaria.
ABSTRACT:
Introduction. At the time of diagnosis, gastric cancer is usually an advanced disease. This is related to poor prognosis. Despite of reported improvement of perioperative results after neoadjuvant therapy In cases of locally advanced disease without evidence of distant metastases, only multivisceral resections may be considered as an attempt to achieve better outcome. Typically, these are very challenging surgical interventions involving different organs in the supramezolic part of the abdominal cavity, requiring great practical experience from the surgical team with potential risks of serious complications.
Aim. To analyze the perioperative results in a group of 59 patients with multivaseral resections of locally advanced T4 gastric cancer without data of distant metastases in hepatobiliary and pancreatic surgery clinic with a large volume of activity.
Material and method. This report is based on a series of 59 patients operated in the Hepato-billiary, Pancraetic and General Surgery Department with T4 locally advanced gastric carcinoma and performed multivaseral resections. This series is subject to a retrospective study.
Results. All patients in the reported group had macroscopic involvement of adjacent organs or anatomical structures without evidence of distant peritoneal or liver dissemination. 36 (61.0%) men and 23 (39.0%) women between the age of 23 and 79 were operated on. Pancreatic resections were performed in 38 (64.4%) patients. In the study group, 2 patients died, with a perioperative mortality rate of 3.3%. Perioperative complications were recorded in 13 patients (22.0%). The most common complication is the postoperative development of pancreatic fistula. The median hospital stay is 10.7 days.
Conclusion. In selected patients, multivisceral resections for locally advanced gastric cancer by an experienced HBP surgical team are associated with acceptable perioperative outcomes in terms of complications and mortality.
Keywords: multivisceral, gastric resection, gastric cancer, radical,
- Download FULL TEXT /PDF 937 KB/
Please cite this article as: Marinov V. Multivisceral resections in cases of locally advanced gastric cancer. Perioperative results in a high-volume center. J of IMAB. 2024 Jul-Sep;30(3):5754-5757. [Crossref - 10.5272/jimab.2024303.5754]
Correspondence to: Assoc. Prof. Vesselin Marinov MD, PhD, Acibadem City Clinic “Tokuda” Hospital, Sofia; 51B, Nikola Vaptsarov Blvd., 1612 Sofia, Bulgaria; E-mail: doc.vesselinmarinov@gmail.com
REFERENCES:
1. Xiao H, Xie P, Zhou K, Qiu X, Hong Y, Liu J, et al. Clavien-Dindo classification and risk factors of gastrectomy-related complications: an analysis of 1049 patients. Int J Clin Exp Med. 2015 May 15;8(5):8262-8. [PubMed]
2. Carboni F, Lepiane P, Santoro R, Lorusso R, Mancini P, Sperduti I, et al. Extended multi-organ resection for T4 gastric carcinoma: 25-year experience. J Surg Oncol. 2005 May 1;90(2):95-100. [PubMed]
3. Watanabe A, Maehara Y, Okuyama T, Kakeji Y, Korenaga D, Sugimachi K. Gastric carcinoma with pyloric stenosis. Surgery. 1998 Mar;123(3):330-4. [PubMed]
4. Lee HJ, Park DJ, Yang HK, Lee KU, Choe KJ. Outcome after emergency surgery in gastric cancer patients with free perforation or severe bleeding. Dig Surg. 2006 Oct;23(4):217-223. [Crossref]
5. Gunderson LL, Sosin H. Adenocarcinoma of the stomach- areas of failure in a reoperation series (second or symptomatic look). Clinicopathological correlation and implications for adjuvant therapy. Int J Radiol Oncol Biol Phys. 1982 Jan;8(1):1-11. [PubMed]
6. Rajdev L. Treatment options for surgically resectable gastric cancer. Curr Treat Options Oncol. 2010 Jun;11(1-2):14–23. [PubMed]
7. Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, et al. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute. J Surg Oncol. 2007 May 1;95(6):461–8. [PubMed]
8. Sasako M, Saka M, Fukagawa T, Katai H, Sano T. [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial]. [in Japanese] Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:110-6. [PubMed]
9. Min JS, Jin SH, Park S, Kim SB, Bang HY, Lee JI. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type. Ann Surg Oncol. 2012 Feb;19(2):494-501. [PubMed]
10. Tran TB, Worhunsky DJ, Norton JA, Squires MH 3rd, Jin LX, Spolverato G, et al. Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S840-7. [PubMed]
11. Martin RC 2nd, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg. 2002 Aug;236(2):159-65. [PubMed]
12. Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Hleyer L, Coburn NG. Multivisceral resection for gastric cancer: a systemic review. Gastric cancer. 2012 Sep;15 Suppl 1:S100-7. [PubMed]
13. Pacelli F, Cusumano G, Rosa F, Marrelli D, Dicosmo M, Cipollari C, et al. Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study. JAMA Surg. 2013 Apr;148(4):353-60. [PubMed]
14. Thakur B, Devkota M, Sharma A, Chaudhary M. Evidence Based Surgical Approach to Locally Advanced Gastric Cancer. J Nepal Health Res Conc. 2019 Aug 4;17(2):133-140. [PubMed]
15. Yang Y, Hu J, Ma Y, Chen G, Liu Y. Multivisceral resection for locally advanced gastric cancer: A retrospective study. Am J Surg. 2021 May; 221(5):1011-1017. [PubMed]
20. Xiao H, Ma M, Xiao Y, Ouyang Y, Tang M, Zhou K, et al. Incomplete resection and linitis plastica are factors for poor survival after extended multi-organ resection in gastric cancer patients. Sci Rep. 2017 Nov 17;7(1):15800. [PubMed ]
17. Tang S, Liu F, Li Y, Zhao L, Wang X, Khan SA, et al. Treatment selection and survival outcomes in locally advanced proximal gastric cancer: a national cancer data base analysis. Front Oncol. 2020 Sep 25:10:537051. [PubMed]
18. Mongan AM, Kalachand R, King S, O'Farrell NJ, Power D, Ravi N, et al. Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery. Ir J Med Sci. 2015 Jun;184(2):417-23. [PubMed]
19. Aversa JG, Diggs LP, Hagerty BL, Dominguez DA, Ituarte PHG, Hernandez JM, et al. Multivisceral resection for locally advanced gastric cancer. J Gasst Surg. 2021 Mar;25(3):609-622. [PubMed]
20. Shimoda Y, Fujikava H, Komori K, Watanabe H, Kano K, Yamada T, et al. Preoperative utility of the Glasgow prognostic score on outcomes of patients with locally advanced gastric cancer. J Gastrointest Cancer. 2022 Jun;53(2):265-271. [PubMed]
Received: 21 May 2024
Published online: 27 September 2024